Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract

  • Technology appraisal guidance
  • TA272
  • Published: 

Transitional cell carcinoma of the urothelial tract - vinflunine: register to attend the appeal

The Institute has received one appeal against the Final Appraisal Determination and Guidance on this technology. The Institute has arranged the hearing for the appeal(s) received against the FAD for the above technology. The appeal panel will convene on Monday 23 May 2011 at NICE, Level 1a City Tower, Piccadilly Plaza, Manchester M1 4BD to hear oral representations from the appellants.

The registration period for this appeal has now passed.

This page was last updated: 06 April 2011